2005
DOI: 10.1111/j.1464-410x.2005.05643.x
|View full text |Cite
|
Sign up to set email alerts
|

Sildenafil inhibits the formation of superoxide and the expression of gp47phox NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells

Abstract: assessed using Western blot analysis. The role of NAD[P]H oxidase and cGMP was further studied by using specific inhibitors of each. RESULTSSuperoxide formation was significantly greater in cells incubated with U46619 after 1 and 16 h incubation than in controls, an effect blocked by NADP(H) oxidase inhibitors. These effects of U46619 were inhibited by sildenafil (1 and 10 nmol/L), which in turn were negated by the guanylyl cyclase inhibitor, ODQ; 10 nmol/L sildenafil inhibited p47phox expression induced by U4… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

15
90
1
2

Year Published

2006
2006
2016
2016

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 105 publications
(108 citation statements)
references
References 19 publications
(41 reference statements)
15
90
1
2
Order By: Relevance
“…In mouse erectile tissue, the soluble guanylyl cyclase stimulator BAY 41-2272 reduces superoxide anion formation through inhibition of NADPH oxidase activity and reduction of NADPH oxidase subunit gp91 phox expression, an effect mediated by a cGMP-dependent mechanism (Teixeira et al, 2007;Nunes et al, 2015). Likewise, the PDE5 inhibitor sildenafil inhibits p47 phox NADPH oxidase subunit expression and superoxide anion formation in cavernosal smooth muscle cells (Koupparis et al, 2005). In contrast, the NO donor DETANONOate inhibits NADPH oxidase-dependent superoxide anion production by a cGMP-independent mechanism in human endothelial cells, without changing the protein expression of gp91 phox (Selemidis et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…In mouse erectile tissue, the soluble guanylyl cyclase stimulator BAY 41-2272 reduces superoxide anion formation through inhibition of NADPH oxidase activity and reduction of NADPH oxidase subunit gp91 phox expression, an effect mediated by a cGMP-dependent mechanism (Teixeira et al, 2007;Nunes et al, 2015). Likewise, the PDE5 inhibitor sildenafil inhibits p47 phox NADPH oxidase subunit expression and superoxide anion formation in cavernosal smooth muscle cells (Koupparis et al, 2005). In contrast, the NO donor DETANONOate inhibits NADPH oxidase-dependent superoxide anion production by a cGMP-independent mechanism in human endothelial cells, without changing the protein expression of gp91 phox (Selemidis et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…21,29 Here we found that sildenafil therapy significantly reduces oxidative stress in ischemic tissues of ApoE Ϫ/Ϫ mice. Therefore, it is conceivable that the antioxidant properties of sildenafil 30,31 could contribute to restore angiogenesis in hypercholesterolemic conditions. Recent studies suggest that postnatal neovascularization relies not exclusively on the sprouting of mature endothelial cells in preexisting vessels (angiogenesis) but also involves A and B, The number of bone marrow-derived EPCs was assessed using 1,1Ј-dioetadeeyl-3,3,3Ј,3Ј-tetramethylindocarboeyanine perchlorate acetylated low-density lipoprotein (DiIacLDL), fluorescein isothiocyanate (FITC)-lectin, and 4Ј,6-diamidino-2-phenylindole (DAPI) stains (A).…”
Section: Discussionmentioning
confidence: 99%
“…These observations suggest a role for intracellular ROS in controlling protein expression and represent a potential mechanism for regulating TP expression. This currently untested hypothesis is especially interesting given that NADPH oxidase, a major source of vascular ROS (15), is an effector for TP (16,17), while antagonism of the TP offset NADPH oxidase expression and renal oxidant stress in diabetic hyperlipidemic mice (18). Indeed, similar to other vasoactive mediators (15), NADPH oxidase-derived cellular ROS may be integral to TxA 2 ʼs cardiovascular actions (16,17).…”
Section: Analog [1s-1a2b(5z)3a(1e3r*)4a]]-7-[3-(3-hydroxy-4-(4′-imentioning
confidence: 99%